查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1597763

超级崩散剂市场：按类型、配方、治疗领域划分 - 2025-2030 年全球预测

Superdisintegrants Market by Type (Natural Superdisintegrants, Synthetic Superdisintegrants), Formulation (Mouth-Dissolving Films, Tablets & Capsules), Therapeutic Area - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年超级崩散剂市值为5.6793亿美元，预计到2024年将达到6.2944亿美元，复合年增长率为10.92%，到2030年将达到11.7348亿美元。

超级崩散剂是製药工业的重要组成部分，主要用于锭剂和胶囊剂的配製，在与生物体液接触时迅速崩坏，从而保证药物的快速释放和吸收。这种需求源于对高效药物传输系统不断增长的需求，其应用涵盖各种类型的口服固态。最终用途范围主要包括需要有效的即时释锭剂和胶囊崩坏解决方案的製药商。该市场的驱动因素包括人口老化需要速效治疗、製药技术的进步以及向严重依赖高效製造製程的学名药的转变。此外，药物配方的创新继续推动对更好配方的需求，为公司提供开发性能、生物相容性和成本效益更高的新型化合物的机会。医疗基础设施不断扩大的新兴市场具有巨大的成长潜力。然而，严格的监管要求以及创新和品管的高成本可能会阻碍快速的市场进入和成长。生物聚合物等新来源的研究和开发可以带来突破，最大限度地降低生产成本并解决安全问题。此外，对个人化医疗和以患者为中心的药物输送系统的关注可能会刺激超级崩散剂的创新，以满足特定患者的需求，例如客製化的药物释放曲线。市场竞争格局的特征是不断创新和产品差异化，这需要着重研发和策略联盟。鼓励公司投资先进製造技术和永续实践，以保持领先地位。最后，有效应对监管环境可以缩短新崩坏製剂的上市时间并提高市场地位。

主要市场统计
基准年[2023] 56793万美元
预测年份 [2024] 6.2944亿美元
预测年份 [2030] 117,348 万美元
复合年增长率（%） 10.92%

市场动态：揭示快速发展的超级崩散剂市场的关键市场洞察

供应和需求的动态相互作用正在改变超级崩散剂市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 口溶锭和胶囊的消耗量增加
    • 学名药的采用增加
  • 市场限制因素
    • 对产品安全和品质的担忧
  • 市场机会
    • 製药业新型超级崩散剂的开发
    • 接受天然超级崩散剂
  • 市场问题
    • 製造超级崩散剂的高成本

波特的五力：驾驭超级崩散剂市场的策略工具

波特的五力框架是了解超级崩散剂市场竞争格局的关键工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解超级崩散剂市场的外部影响

外部宏观环境因素在塑造超级崩散剂市场的表现动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解超级崩散剂市场的竞争状况

对超级崩散剂市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：超级崩散剂市场供应商绩效评估

FPNV定位矩阵是评估超级崩散剂市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製超级崩散剂市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对超级崩散剂市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 口溶锭和胶囊的消耗量增加
      • 学名药的采用增加
    • 抑制因素
      • 对产品安全和品质的担忧
    • 机会
      • 医药产业新型超级崩散剂的开发
      • 接受天然超级崩散剂
    • 任务
      • 製造超级崩散剂的高成本
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章超级崩散剂市场：依类型

  • 介绍
  • 天然超级崩散剂
    • 胶
    • 黏液
    • 车前子黏液
  • 合成超级崩散剂
    • 硅酸钙
    • 交聚维酮
    • 离子交换树脂
    • 改性纤维素
      • 交联羧甲基纤维素钠
      • 低取代羟丙基纤维素
    • 改质淀粉

第七章超级崩散剂市场：按配方

  • 介绍
  • 口腔溶解膜
  • 锭剂和胶囊

第八章超级崩散剂市场：依治疗领域

  • 介绍
  • 心血管疾病
  • 消化系统疾病
  • 血液疾病
  • 感染疾病
  • 发炎疾病
  • 神经系统疾病
  • 肿瘤学

第九章 北美、南美超级崩散剂市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太超级崩散剂市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲超级崩散剂市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Anshul Life Sciences
  • Asahi Kasei Corporation
  • Ashland Global Specialty Chemicals Inc.
  • Avantor Performance Materials, LLC
  • BASF SE
  • DFE Pharma GmbH & Co KG
  • DowDuPont Inc.
  • FMC Corporation
  • Gangwal Chemicals Pvt. Ltd.
  • Huber Corporation
  • JRS PHARMA GmbH+Co. KG
  • Nippon Soda Co., Ltd.
  • NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD.
  • Roquette Freres SA
  • Sigachi Industries Pvt Ltd.
Product Code: MRR-4103B31E087F

The Superdisintegrants Market was valued at USD 567.93 million in 2023, expected to reach USD 629.44 million in 2024, and is projected to grow at a CAGR of 10.92%, to USD 1,173.48 million by 2030.

Superdisintegrants are critical components in the pharmaceutical industry, primarily used in the formulation of tablets and capsules to facilitate their rapid disintegration upon contact with biological fluids, hence ensuring quick drug release and absorption. Their necessity arises from the growing demand for efficient drug delivery systems, and their applications span across various types of oral solid dosage forms. The end-use scope primarily includes pharmaceutical manufacturers who require effective disintegration solutions for immediate-release tablets and capsules. The market is driven by factors such as an increasing aging population needing rapid-acting therapeutics, advances in pharmaceutical technologies, and the shift towards generic drugs which rely heavily on efficient production processes. Furthermore, innovations in drug formulation continue to propel the need for better superdisintegrants, presenting opportunities for companies to develop novel compounds offering improved performance, biocompatibility, and cost-effectiveness. Emerging markets with expanding healthcare infrastructure provide considerable potential for growth. However, limitations exist due to stringent regulatory requirements and high costs of innovation and quality control, which can hinder quick market access and thus growth. Research and development into new sources of superdisintegrants, such as biopolymers, could provide breakthroughs, minimizing production costs and addressing safety concerns. Moreover, a focus on personalized medicine and patient-centric drug delivery systems could spur innovations in superdisintegrants that align with specific patient needs, such as tailored drug release profiles. The market's competitive landscape is characterized by constant innovation and product differentiation, thereby necessitating a strong emphasis on R&D and strategic collaborations. Companies are recommended to invest in advanced manufacturing technologies and sustainable practices to stay ahead. Lastly, navigating the regulatory landscape efficiently can also create opportunities by accelerating time-to-market for new superdisintegrant formulations, thus enhancing their market position.

KEY MARKET STATISTICS
Base Year [2023] USD 567.93 million
Estimated Year [2024] USD 629.44 million
Forecast Year [2030] USD 1,173.48 million
CAGR (%) 10.92%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Superdisintegrants Market

The Superdisintegrants Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing consumption of orally disintegrating tablets and capsules
    • Rising adoption of the generic drugs
  • Market Restraints
    • Concerns related to the safety and quality of product
  • Market Opportunities
    • Development of new superdisintegrants for the pharmaceutical industry
    • Acceptance of natural superdisintegrants
  • Market Challenges
    • High-cost associated with manufacturing of superdisintegrants

Porter's Five Forces: A Strategic Tool for Navigating the Superdisintegrants Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Superdisintegrants Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Superdisintegrants Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Superdisintegrants Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Superdisintegrants Market

A detailed market share analysis in the Superdisintegrants Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Superdisintegrants Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Superdisintegrants Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Superdisintegrants Market

A strategic analysis of the Superdisintegrants Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Superdisintegrants Market, highlighting leading vendors and their innovative profiles. These include Anshul Life Sciences, Asahi Kasei Corporation, Ashland Global Specialty Chemicals Inc., Avantor Performance Materials, LLC, BASF SE, DFE Pharma GmbH & Co KG, DowDuPont Inc., FMC Corporation, Gangwal Chemicals Pvt. Ltd., Huber Corporation, JRS PHARMA GmbH + Co. KG, Nippon Soda Co., Ltd., NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD., Roquette Freres S.A., and Sigachi Industries Pvt Ltd..

Market Segmentation & Coverage

This research report categorizes the Superdisintegrants Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Natural Superdisintegrants and Synthetic Superdisintegrants. The Natural Superdisintegrants is further studied across Gums, Mucilage, and Plantago Ovata Mucilage. The Synthetic Superdisintegrants is further studied across Calcium Silicates, Crospovidone, Ion Exchange Resins, Modified Cellulose, and Modified Starch. The Modified Cellulose is further studied across Croscarmellose Sodium and Low-Substituted Hydroxypropyl Cellulose.
  • Based on Formulation, market is studied across Mouth-Dissolving Films and Tablets & Capsules.
  • Based on Therapeutic Area, market is studied across Cardiovascular Diseases, Gastrointestinal Diseases, Hematological Diseases, Infectious Diseases, Inflammatory Diseases, Neurological Diseases, and Oncology.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing consumption of orally disintegrating tablets and capsules
      • 5.1.1.2. Rising adoption of the generic drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns related to the safety and quality of product
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of new superdisintegrants for the pharmaceutical industry
      • 5.1.3.2. Acceptance of natural superdisintegrants
    • 5.1.4. Challenges
      • 5.1.4.1. High-cost associated with manufacturing of superdisintegrants
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Superdisintegrants Market, by Type

  • 6.1. Introduction
  • 6.2. Natural Superdisintegrants
    • 6.2.1. Gums
    • 6.2.2. Mucilage
    • 6.2.3. Plantago Ovata Mucilage
  • 6.3. Synthetic Superdisintegrants
    • 6.3.1. Calcium Silicates
    • 6.3.2. Crospovidone
    • 6.3.3. Ion Exchange Resins
    • 6.3.4. Modified Cellulose
      • 6.3.4.1. Croscarmellose Sodium
      • 6.3.4.2. Low-Substituted Hydroxypropyl Cellulose
    • 6.3.5. Modified Starch

7. Superdisintegrants Market, by Formulation

  • 7.1. Introduction
  • 7.2. Mouth-Dissolving Films
  • 7.3. Tablets & Capsules

8. Superdisintegrants Market, by Therapeutic Area

  • 8.1. Introduction
  • 8.2. Cardiovascular Diseases
  • 8.3. Gastrointestinal Diseases
  • 8.4. Hematological Diseases
  • 8.5. Infectious Diseases
  • 8.6. Inflammatory Diseases
  • 8.7. Neurological Diseases
  • 8.8. Oncology

9. Americas Superdisintegrants Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Superdisintegrants Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Superdisintegrants Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Anshul Life Sciences
  • 2. Asahi Kasei Corporation
  • 3. Ashland Global Specialty Chemicals Inc.
  • 4. Avantor Performance Materials, LLC
  • 5. BASF SE
  • 6. DFE Pharma GmbH & Co KG
  • 7. DowDuPont Inc.
  • 8. FMC Corporation
  • 9. Gangwal Chemicals Pvt. Ltd.
  • 10. Huber Corporation
  • 11. JRS PHARMA GmbH + Co. KG
  • 12. Nippon Soda Co., Ltd.
  • 13. NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD.
  • 14. Roquette Freres S.A.
  • 15. Sigachi Industries Pvt Ltd.

LIST OF FIGURES

  • FIGURE 1. SUPERDISINTEGRANTS MARKET RESEARCH PROCESS
  • FIGURE 2. SUPERDISINTEGRANTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. SUPERDISINTEGRANTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. SUPERDISINTEGRANTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SUPERDISINTEGRANTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SUPERDISINTEGRANTS MARKET DYNAMICS
  • TABLE 7. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY GUMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY MUCILAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY PLANTAGO OVATA MUCILAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY CALCIUM SILICATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY CROSPOVIDONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY ION EXCHANGE RESINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY CROSCARMELLOSE SODIUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED STARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY MOUTH-DISSOLVING FILMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS & CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY HEMATOLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY INFLAMMATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 284. SUPERDISINTEGRANTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 285. SUPERDISINTEGRANTS MARKET, FPNV POSITIONING MATRIX, 2023